Board of Directors

Leo Roucher
With a history of serial successes, Mr. Roucher brings a unique expertise in the area of start-up, development and sale of medical technology companies. Mr. Roucher was founder and CEO of Navius Corporation, developer and manufacturer of cardiac balloon angioplasty catheters and cardiac stents, which was acquired by Endosonics Corporation for $20M. Mr. Roucher spearheaded angioplasty development for SciMed, which subsequently sold to Boston Scientific in 1994 for $1.6B, and Versaflex, Inc. which sold to Medtronic for $96M. He has over 20 years of hands-on executive experience in the medical device industry, with companies which also

Jeffery Schipper
Mr. Schipper has over 20 years of experience in executive positions in major healthcare companies including Johnson & Johnson, Imed Corporation, and Sybron Corporation. He has proven success in startup medical technology companies, including Navius Corporation, an interventional cardiology firm, where he served as VP of Engineering and Quality Systems. Mr. Schipper is currently President and CEO of Sierra Medical Technology Inc., a medical engineering consultancy firm. Sierra provides contract services to Restech.

Wayne Yamamoto
Mr. Yamamoto has a successful record of executive management leading companies through rapid growth over the last 27 years. Mr. Yamamoto serves on the Board of Directors for Restech and acts as CEO for Securesoft Systems, an enterprise compliance and risk management solutions company for the Healthcare market.